[{"id":"f2afbf99-2029-4f29-86c4-41a5cc58b54c","acronym":"","url":"https://clinicaltrials.gov/study/NCT04886986","created_at":"2021-05-14T12:52:39.196Z","updated_at":"2024-07-02T16:35:39.458Z","phase":"Phase 1/2","brief_title":"Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I\u0026T for Progressive Metastatic Castration Resistant Prostate Cancer","source_id_and_acronym":"NCT04886986","lead_sponsor":"Weill Medical College of Cornell University","biomarkers":" CYP17A1","pipe":"","alterations":" ","tags":["CYP17A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lutetium zadavotide guraxetan (PNT2002) • Ac-225 rosopatamab tetraxetan (CONV01-α)"],"overall_status":"Suspended","enrollment":" Enrollment 48","initiation":"Initiation: 06/30/2021","start_date":" 06/30/2021","primary_txt":" Primary completion: 12/24/2024","primary_completion_date":" 12/24/2024","study_txt":" Completion: 12/27/2027","study_completion_date":" 12/27/2027","last_update_posted":"2023-08-21"}]